Steven Gundry is a heart surgeon and functional medicine practitioner. His published medical research focuses on pediatric cardiac surgery, congenital heart disease interventions, and pediatric heart transplantation. His work has also investigated cardiac xenotransplantation models, robotically assisted surgical techniques, and surgical materials such as prosthetic valves and tissue adhesives.
28 claims checked on air: 3 context 5 contradicted 4 overstated 12 supported 4 unverified
"And one of the scary things is people, for instance, with dementia have up to fourfold more bacteria in their brain than hopefully you and I do." (said at 0:00:15)
No published record matching the claim that individuals with dementia have up to fourfold more bacteria in their brain compared to people without dementia was located; this does not prove the claim false.
"So when he became on staff, he mimicked the midwives, and he actually washed his hands and made all of his people wash their hands, and almost instantaneously his results got a whole lot better than all of his other colleagues." (said at 0:06:40)
Historical epidemiological records and modern statistical re-analyses confirm the claim. In 1847 at the Vienna General Hospital (Allgemeines Krankenhaus), Ignaz Semmelweis identified that maternal mortality from puerperal sepsis was significantly higher in Clinic 1 (where doctors and medical students examined women after performing autopsies) than in Clinic 2 (staffed by student midwives who did not conduct autopsies). Semmelweis instituted mandatory hand antisepsis with chlorinated lime solutions for all clinicians before patient examinations, which led to an immediate drop in maternal mortality from an average of over 10% (reaching ~18% in peak months) down to below 2%.
"In this case, a comparison of the average monthly mortality rate before the introduction of handwashing (10.65%, blue points) and after it (1.98%, red points) yields a risk ratio of 5.38... This yields an estimated absolute reduction in maternal mortality of 8.87%, which is highly statistically significant (P = 0.0042)." (abstract)openalexfull study (doi)
"After 1840 maternal mortality was higher in Clinic 1 which was staffed by male obstetricians and medical students who, unlike the midwives in Clinic 2, attended autopsies. The introduction of chlorine washing of the male clinicians' hands in Clinic 1 by Semmelweis in 1847 reduced mortality, whereas the cessation of handwashing after Semmelweis left Vienna in 1850 was associated with increased mortality." (abstract, passage verified)openalexfull study (doi)
"So, this was a a young woman—young woman, 62 years old, she's a physician... who had developed uh really bad Parkinson's... we had done leaky gut tests on her... we put her on my program... she did not have a tremor... And her downhill that she felt started shortly after he arrived." (said at 0:10:12)
No published record matching the reported clinical case of a 62-year-old female physician experiencing resolution of Parkinson's disease symptoms following dietary treatment for intestinal permeability, followed by relapse attributed to gluten cross-contamination, was located; this does not prove the claim false.
"And you know 80% of our immune cells, our white blood cells, are down in our gut." (said at 0:18:25)
While the gastrointestinal tract is a major immunological site containing substantial mucosal-associated lymphoid tissue (and produces a large fraction of secretory antibodies such as IgA), the claim that 80% of all immune cells (white blood cells) reside in the gut is contradicted by quantitative anatomical cell surveys. Comprehensive mapping of immune cells in the human body shows that the majority of human white blood cells reside in the bone marrow (most neutrophils and precursors) and secondary lymphoid tissues such as the spleen and lymph nodes (the majority of lymphocytes), with the gut housing only a modest fraction (under 5–10%) of total immune cells.
"Lymphocytes constitute 40% of the total number of immune cells and 15% of the mass and are mainly located in the lymph nodes and spleen. Neutrophils account for similar proportions of both the number and total mass of immune cells, with most neutrophils residing in the bone marrow." (abstract, results, passage verified)pubmedfull study (doi)
"my father um had Parkinson's uh for about 25 years. Um and he uh when he first developed it, I was just kind of starting in this, and he was act he did not change in 25 years, did not change his medication, did not change his because I taught my mother um to feed him, I guess. Uh and and funny I'll tell you a funny story... but yeah, he did he was he had Parkinson's for 25 years and died of a totally different reason at 91." (said at 0:24:18)
No published record matching Dr. Steven Gundry's account of his father's 25-year course with Parkinson's disease or specific dietary management was located; this does not prove the claim false. Personal anecdotes and unpublished single-case observations cannot be verified against the peer-reviewed medical literature.
"lo and behold, we find out that it's the gut microbiome themselves that are producing these neurotransmitters or the precursors." (said at 0:26:15)
The human gut microbiota directly produces and metabolizes classical neurotransmitters, including dopamine and serotonin, as well as related neuroactive amines and precursors. Specific bacterial strains express functional enzymes, such as bacterial aromatic L-amino acid decarboxylases (AADCs), that synthesize these monoamines and regulate precursor availability (e.g., tryptophan and tyrosine) within the gut environment.
"The human microbiota produces a diverse array of bioactive molecules, including classic neurotransmitters (dopamine and serotonin) and trace amines (tryptamine, tyramine, and phenylethylamine). Although long considered products of host metabolism, these aromatic monoamines are now also known to originate in part from the microbiota, where they are synthesized by bacterial aromatic L-amino acid decarboxylases (AADCs)." (abstract, results, passage verified)pubmedfull study (doi)
"Beyond its established roles in digestion, immune regulation, and enteroendocrine signaling, the gut microbiota (GM) influences distant organs, particularly the brain, by producing or modulating the balance of neurotransmitters (NTs) and regulating their intestinal metabolism through epigenetic mechanisms, thereby shaping gut-brain communication." (abstract, background, passage verified)pubmedfull study (doi)
"And then to come to find out that these tryptophan pathway bacteria are selectively killed by glyphosate, the active ingredient in Roundup." (said at 0:26:40)
Glyphosate inhibits 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS), an enzyme in the shikimate pathway used by plants and some microorganisms to synthesize aromatic amino acids, including tryptophan. However, stating that bacteria responsible for this pathway are 'selectively killed' in the gut overstates the evidence. Metagenomic and metatranscriptomic analyses of the human gut microbiome demonstrate that most gut bacterial species lack a complete shikimate pathway, rely on dietary aromatic amino acids (auxotrophy), or carry glyphosate-insensitive (class II) EPSPS enzymes, making them largely unaffected. Furthermore, while in vivo rodent studies confirm that glyphosate can inhibit the EPSPS enzyme in the gut (evidenced by the accumulation of shikimic acid in the caecum), this enzymatic inhibition does not cause a selective kill-off or major depletion of the microbial community.
"Glyphosate and MON 52276 treatment resulted in ceca accumulation of shikimic acid and 3-dehydroshikimic acid, suggesting inhibition of 5-enolpyruvylshikimate-3-phosphate synthase of the shikimate pathway in the gut microbiome... Shotgun metagenomics of the cecum showed that treatment with glyphosate and MON 52276 resulted in higher levels of Eggerthella spp., Shinella zoogleoides , Acinetobacter johnsonii , and Akkermansia muciniphila ." (abstract, results, passage verified)pubmedfull study (doi)
"Comparison of the abundance of the shikimate pathway in 734 paired metagenomes and metatranscriptomes indicated that most gut bacteria do not possess a complete shikimate pathway, and that this pathway is mostly transcriptionally inactive in the human gut microbiome. This suggests that gut bacteria are mostly aromatic amino acid auxotrophs and thus relatively resistant to a potential growth inhibition by glyphosate." (abstract, results, passage verified)pubmedfull study (doi)
"And Roundup was patented as an antibiotic. It wasn't a weed killer." (said at 0:26:50)
The claim that glyphosate (Roundup) was originally patented as an antibiotic rather than an herbicide is contradicted by historical patent records and chemical literature. Glyphosate was first synthesized in 1950 by Swiss chemist Henri Martin at Cilag, where it was investigated as a metal chelating agent (and patented as such under Swiss Patent CH377080, later US Patent 3,160,632). Its herbicidal properties were discovered in 1970 by John E. Franz at Monsanto, leading to its registration and original patent as a broad-spectrum herbicide (US Patent 3,799,758, issued in 1974). Monsanto later obtained a patent for its antimicrobial properties in 2010 (US Patent 7,771,736), decades after its initial synthesis as a chelator and its development and marketing as an herbicide. While glyphosate does possess antimicrobial properties by inhibiting the shikimate pathway in susceptible bacteria (PMID: 41953436, PMID: 42041382), it was not originally patented or developed as an antibiotic.
"Glyphosate, the world's most widely used herbicide with known bactericidal properties, targets the shikimate pathway and may thus exert selective pressure favoring resistant bacteria" (abstract, passage verified)pubmedfull study (doi)
"Glyphosate-based formulations are globally pervasive pollutants increasingly recognized as potential contributors to antimicrobial resistance (AMR) in environmental microbiomes. Although glyphosate is designed to inhibit plant 5-enolpyruvylshikimate-3-phosphate synthase, it also affects microbial metabolism" (abstract, passage verified)pubmedfull study (doi)
"And lo and behold, we now know that these drugs actually change the microbiome to a more favorable um tryptophan pathway microbiome. And so even these drugs, the effect was actually on the microbiome." (said at 0:27:20)
Selective serotonin reuptake inhibitors (SSRIs) exert their primary therapeutic effects by binding to and inhibiting the serotonin transporter (SERT) in the central nervous system, increasing synaptic serotonin concentration and downstream neuroplasticity. While recent research demonstrates that SSRIs can alter gut microbiota composition and downstream tryptophan/indole metabolites (PMID 31273200, PMID 40176389), and that baseline microbiome composition correlates with treatment response (PMID 39695082), these gut interactions are modulating or secondary effects. Evidence regarding the microbiota-gut-brain axis in psychotropic drug response remains heterogeneous and largely associative (PMID 42316492). Claiming that the therapeutic effect of SSRIs is "actually on the microbiome" rather than central serotonin reuptake inhibition contradicts established neuropharmacology.
"Overall, exposure to escitalopram/citalopram results in shifts in metabolism through noncanonical pathways, which suggest possible roles for the gut microbiome, oxidative stress, and inflammation-related mechanisms." (abstract, results, passage verified)pubmedfull study (doi)
"In conclusion, gut microbiota influences the antidepressant effects of SSRIs through metabolic pathways. The diversity and function of gut microbiota can serve as biomarkers for predicting the treatment response, providing new insights for personalized treatment." (abstract, conclusions, passage verified)pubmedfull study (doi)
"Although the microbiota-gut-brain axis represents a biologically plausible and clinically relevant determinant of psychotropic outcomes, current evidence remains heterogeneous and largely associative." (abstract, results, passage verified)pubmedfull study (doi)
"And we know from animal experiments that we can take a happy rat and have it eat poop from a depressed individual and the rat will become depressed. Uh we joke rats love to eat poop. So and and conversely we can take a happy people's microbiome and have a depressed rat eat that and they'll become happy." (said at 0:27:40)
Preclinical animal research demonstrates that fecal microbiota transplantation (FMT) from humans diagnosed with major depressive disorder into microbiota-depleted rodents induces depressive-like and anxiety-like behaviors (such as anhedonia) as well as altered tryptophan metabolism (PMID: 27491067). However, the claim oversimplifies and overstates the literature in several ways: the experiments involve oral gavage into antibiotic-depleted or germ-free rodent models rather than animals freely eating feces to transfer phenotypes, and while healthy human microbiota transfers have been used as non-depressed control baselines, evidence showing complete reversal or 'curing' of pre-existing depression in rodents by transplanting healthy human microbiota is considerably more preliminary and conditional. Evidence is restricted to rodent models, yielding very low certainty for human clinical relevance.
"Fecal microbiota transplantation from depressed patients to microbiota-depleted rats can induce behavioural and physiological features characteristic of depression in the recipient animals, including anhedonia and anxiety-like behaviours, as well as alterations in tryptophan metabolism." (abstract, results, passage verified)pubmedfull study (doi)
"there's actually beautiful work in human studies with alcohol uh rehab. People who have the most dysbiotic alcohol seeking microbiome are the biggest failures in treatment and the people who have the least alcohol seeking microbiome are the best chances to make it through." (said at 0:30:32)
Clinical studies (notably seminal work by Leclercq et al., 2014) have demonstrated an association between gut microbiota dysbiosis, increased intestinal permeability, and higher psychological markers of relapse risk (such as elevated alcohol craving, depression, and anxiety) in alcohol-dependent patients undergoing short-term rehabilitation/detoxification. However, characterizing this as definitive proof that an 'alcohol-seeking microbiome' dictates treatment failure versus success overstates the findings. The available human research primarily evaluates surrogate psychological markers (craving and negative affect during early abstinence) in small observational cohorts rather than long-term clinical treatment failure or relapse endpoints, and the label 'alcohol seeking microbiome' is an oversimplification of complex dysbiotic shifts.
"We found that some, but not all, alcohol-dependent subjects developed gut leakiness, which was associated with higher scores of depression, anxiety, and alcohol craving after 3 wk of abstinence, which may be important psychological factors of relapse. Moreover, subjects with increased gut permeability also had altered composition and activity of the gut microbiota." (abstract, results, passage verified)pubmedfull study (doi)
"what they've done again in experimental animals, they'll wipe out this opioid seeking microbiome with antibiotics and then kind of instantly these animals a tiny dose of a narcotic is enough to give an effect. Then you reintroduce this opioid seeking microbiome and instantly, I mean the next day, they're back to, "Oh my gosh, I have I need this huge dose to have the same effect."" (said at 0:31:44)
Animal studies support the claim. In rodent models of chronic morphine administration, gut microbiota depletion using broad-spectrum antibiotic regimens or germ-free conditions significantly attenuates the development of morphine analgesic tolerance, allowing the drug to maintain antinociceptive efficacy. Furthermore, fecal microbiota transplantation or reconstitution of germ-free mice with microbiota reinstates morphine tolerance. Evidence is currently limited to preclinical animal models.
"In addition, ABX prevented the development of antinociceptive tolerance to chronic morphine in both the tail-immersion and acetic acid stretch assays." (abstract, results, passage verified)pubmedfull study (doi)
"We show that morphine analgesic tolerance was significantly attenuated in germfree (GF) and in pan-antibiotic-treated mice. Reconstitution of GF mice with naïve fecal microbiota reinstated morphine analgesic tolerance." (abstract, results, passage verified)pubmedfull study (doi)
"Toxoplasmosis goes to the brain of the rat and using the dopamine pathway simplistically rewires the brain of this advanced organism to love the smell of cat urine, to get sexually excited by cat urine and the sight of a cat, and to run to find that cat, run to danger, and of course the cat eats the rodent and the life cycle is completed." (said at 0:34:09)
Published neurobiological and behavioural research in rodent models demonstrates that Toxoplasma gondii infection shifts the rodent's innate aversion to cat odor into attraction. Specifically, neuroimaging and c-Fos mapping show that exposure to cat urine in infected male rats activates posterodorsal medial amygdala and hypothalamic pathways typically dedicated to sexual arousal/attraction rather than the classical defensive fear pathways. T. gondii infection is also documented to alter dopaminergic circuitry in the amygdala and brain tissue. Because this evidence is derived entirely from animal and mechanistic studies, the GRADE certainty is rated as very low.
"Moreover, Toxoplasma increases activity in nearby limbic regions of sexual attraction when the rat is exposed to cat urine, compelling evidence that Toxoplasma overwhelms the innate fear response by causing, in its stead, a type of sexual attraction to the normally aversive cat odor." (abstract, results, passage verified)pubmedfull study (doi)
"Infection with the parasite is associated with a demethylation of the promoters of certain genes in the cerebral amygdala of the intermediate hosts, modifying dopaminergic circuits associated with fear." (abstract, results, passage verified)pubmedfull study (doi)
"And we know in Yellowstone Park that the most of the pack leaders in Yellowstone Park are infected with toxoplasmosis. Why? Because they're willing to take risks." (said at 0:35:25)
A 26-year study of gray wolves (Canis lupus) in Yellowstone National Park published in 2022 examined the behavioral effects of Toxoplasma gondii infection. The researchers found that seropositive wolves were significantly more likely to engage in high-risk behaviors, including natal dispersal (11 times more likely) and becoming a pack leader (more than 46 times more likely than uninfected wolves). This observational cohort study supports the claim that T. gondii infection is strongly associated with pack leadership through parasite-induced risk-taking behavior.
"In addition, seropositive wolves were more likely to make high-risk decisions such as dispersing and becoming a pack leader, both factors critical to individual fitness and wolf vital rates." (abstract, results, passage verified)pubmedfull study (doi)
"And what's really wild is that most most motorcycle accident victims are infected with toxoplasmosis." (said at 0:37:05)
While observational studies and meta-analyses have found a statistically significant association between latent Toxoplasma gondii infection and an increased risk of traffic accidents (with pooled odds ratios around 1.69 and a population attributable fraction around 17%), it is not true that "most" motorcycle or traffic accident victims are infected. Studies specifically evaluating motorcycle crash victims report seroprevalence rates far below a majority (e.g., 12.5% in a case-control study).
"We found a significant association for antibodies against T. gondii with TA [odds ratio (OR) = 1.69; 95% confidence interval (CI) 1.20-2.38, p = 0.003] and SA (OR = 1.39; 95% CI 1.10-1.76, p = 0006)... PAF of a T. gondii infection was 17% for TA and 10% for SA." (abstract, results)pubmedfull study (doi)
"Eleven of 88 (12.5%) in the case group and 22 of 88 (25.0%) in controls were positive for anti-T. gondii IgG antibodies, this difference was statistically significant (OR = 0.42; CI: 0.19-0.95, p = 0.03)." (abstract, results, passage verified)pubmedfull study (doi)
"We have a sugar molecule in us called Neu5Ac. It's also in fish and poultry. Neu5Gc and Neu5Ac look identical except for one molecule of oxygen. They're otherwise identical... When we swallow Neu5Gc, we make a very aggressive antibody to it. We hate it. What's interesting is we will incorporate Neu5Gc into our various glycocalyces and displace Neu5Ac. And the more of these foods we eat, the more it's displaced. And then we attack it as a foreign substance." (said at 0:40:20)
The speaker's statement accurately summarizes the established biochemistry and immunology surrounding Neu5Gc and Neu5Ac in humans. Neu5Gc (N-glycolylneuraminic acid) differs from endogenous human Neu5Ac (N-acetylneuraminic acid) by a single hydroxyl oxygen atom added by the CMP-Neu5Ac hydroxylase (CMAH) enzyme, which is mutated and non-functional in humans. Neu5Gc is selectively enriched in red meat (beef, pork, lamb) and dairy products, but rare in poultry and fish. When humans ingest dietary Neu5Gc, it is metabolically absorbed and incorporated into newly synthesized glycoconjugates (glycocalyx) across human tissues, displacing Neu5Ac. Because the human immune system recognizes Neu5Gc as foreign, circulating anti-Neu5Gc antibodies (IgG, IgM, IgA) are produced and target these incorporated glycans, leading to immune activation and chronic inflammation (xenosialitis).
"We found that Neu5Gc is rare in poultry and fish, common in milk products, and enriched in red meats. Furthermore, normal humans have variable amounts of circulating IgA, IgM, and IgG antibodies against Neu5Gc, with the highest levels comparable to those of the previously known anti-alpha-galactose xenoreactive antibodies. This finding represents an instance wherein humans absorb and metabolically incorporate a nonhuman dietary component enriched in foods of mammalian origin, even while generating xenoreactive, and potentially autoreactive, antibodies against the same molecule." (abstract, passage verified)pubmedfull study (doi)
"We used an improved method to survey common foods for free and glycosidically bound forms of the nonhuman sialic acid N-glycolylneuraminic acid (Neu5Gc), showing that it is highly and selectively enriched in red meat. The bound form of Neu5Gc is bioavailable, undergoing metabolic incorporation into human tissues, despite being a foreign antigen. Interactions of this antigen with circulating anti-Neu5Gc antibodies could potentially incite inflammation." (abstract, passage verified)pubmedfull study (doi)
"Neu5Gc and Neu5Ac look identical except for one molecule of oxygen. They're otherwise identical." (said at 0:40:20)
N-acetylneuraminic acid (Neu5Ac) and N-glycolylneuraminic acid (Neu5Gc) differ in chemical structure by a single oxygen atom. Neu5Gc possesses an additional oxygen atom in the form of a hydroxyl group attached to the N-acetyl methyl group (forming an N-glycolyl group), a modification mediated by the enzyme CMP-N-acetylneuraminic acid hydroxylase (CMAH). Although the speaker colloquially said 'molecule of oxygen' rather than 'oxygen atom', the core statement that the two sialic acids differ chemically by a single oxygen atom is well-established.
"The sialic acids N-acetylneuraminic acid (Neu5Ac) and N-glycolylneuraminic acid (Neu5Gc) differ by a single oxygen atom and are widely found at the terminal position of glycans on vertebrate cell surfaces." (abstract, background, passage verified)pubmedfull study (doi)
"These findings suggest that the loss of a single oxygen atom in sialic acid during human evolution may have significantly influenced hydrophobic properties, contributing to alterations in binding affinity and molecular interactions." (abstract, conclusions, passage verified)pubmedfull study (doi)
"And what's interesting, even animals that have Neu5Gc will not let Neu5Gc in their brain because it is so inflammatory. Even in an animal who makes Neu5Gc, that was one big surprises to me." (said at 0:41:25)
The speaker correctly notes that animals capable of synthesizing N-glycolylneuraminic acid (Neu5Gc) suppress its expression in the brain. However, the claim that Neu5Gc is excluded from the brain specifically because of its inflammatory properties is an oversimplification or extrapolation. Research confirms that across vertebrates, Neu5Gc expression in neural tissue is suppressed to trace or undetectable levels despite being synthesized in extraneural tissues. Forced overexpression of Neu5Gc in the brains of transgenic mice causes neurodevelopmental and cognitive impairments—such as abnormal locomotor activity, impaired memory, altered axon myelination, and heightened vulnerability to certain bacterial toxins—rather than primary inflammatory brain damage. While Neu5Gc is known to trigger inflammation in humans (who lack the CMAH gene and make anti-Neu5Gc antibodies), animals that naturally synthesize Neu5Gc produce it in non-neural tissues without self-directed inflammatory reactions. The evolutionary suppression of Neu5Gc in the brain appears driven by its negative impacts on neural structural and functional integrity and pathogen vulnerability rather than intrinsic inflammatory properties within those animals.
"In animals capable of synthesizing Neu5Gc, most tissues and cell types express both sialic acids, in proportions that vary between species. However, it has long been noted that Neu5Gc is consistently expressed at trace to absent levels in the brains of all vertebrates studied to date." (abstract, passage verified)pubmedfull study (doi)
"Contrasting with other organs that express various ratios of Neu5Ac and Neu5Gc depending on the variable expression of Cmah, Neu5Gc expression in the brain is extremely low in all vertebrates studied to date, suggesting that neural expression is detrimental to animals... Such Neu5Gc overexpression in the brain resulted in abnormal locomotor activity, impaired object recognition memory, and abnormal axon myelination." (abstract, results, passage verified)pubmedfull study (doi)
"the people with the longest uh lifespan as a country uh is Andorra, this little country between Spain and uh and France up in the hills" (said at 0:44:28)
Andorra is frequently cited among the locations with the highest life expectancies in the world (and held the top rank in historical international estimates such as earlier editions of the CIA World Factbook and US Census Bureau projections). However, comprehensive global demographic analyses from the Global Burden of Disease (GBD) study, the World Health Organization, and the United Nations generally rank countries and territories such as Monaco, Japan, Singapore, Switzerland, or Hong Kong as having the highest overall life expectancies at birth.
"Despite this overall progress, there remains substantial variation in life expectancy at birth in 2017, which ranges from 49·1 years (46·5-51·7) for men in the Central African Republic to 87·6 years (86·9-88·1) among women in Singapore." (abstract, results, passage verified)openalexfull study (doi)
"The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 produced updated and comprehensive demographic assessments of the key indicators of fertility, mortality, migration, and population for 204 countries and territories and selected subnational locations from 1950 to 2019." (abstract, background, passage verified)openalexfull study (doi)
"And these fermented sausages, traditional sausages, are fermented. They they have lactic acid bacteria in them. They eat all the Neu5Gc. So these guys are getting great fermented products that doesn't have Neu5Gc. And fermenting milk removes Neu5Gc." (said at 0:44:50)
No published record matching the claim that traditional fermentation of sausages or meats by lactic acid bacteria, or the fermentation of milk, eliminates or removes Neu5Gc was located; this does not prove the claim false. Research has demonstrated that human gut microbiota (such as specific Bacteroidales species expressing specialized sialidases) can liberate and utilize Neu5Gc in the intestine, and Neu5Gc remains detectable in fermented dairy products such as cheddar cheese. However, evidence showing that traditional lactic acid bacterial food fermentation processes degrade or eliminate Neu5Gc from meats or dairy products is lacking.
"We found that a Neu5Gc-rich diet induces changes in the gut microbiota, with Bacteroidales and Clostridiales responding the most. Genome assembling of mouse and human shotgun metagenomic sequencing identified bacterial sialidases with previously unobserved substrate preference for Neu5Gc-containing glycans." (abstract, results, passage verified)pubmedfull study (doi)
"Neu5Gc-positive N-glycans were identified in reduced-fat sharp cheddar cheese (CHE), whereas such structures were not observed in processed cheddar cheese slices (SLI)." (abstract, results, passage verified)pubmedfull study (doi)
"And there and you know the best coronary artery disease in France is in Toulouse, the home of foie gras and sausages in cassoulet." (said at 0:44:50)
Population-based cardiovascular registry data from the WHO MONICA project in France (which systematically monitored acute coronary heart disease across three distinct regions: Lille in the north, Strasbourg in the east, and Toulouse/Haute-Garonne in the southwest) demonstrated a clear north-to-south gradient. Toulouse consistently recorded the lowest coronary heart disease mortality and case-fatality rates among the monitored French regions.
"The case-fatality rates observed 28 days after the onset of the MI, were 30.6% in Lille, 17.5% in Strasbourg and 9.9% in Toulouse (P < 0.0001)." (abstract, results, passage verified)pubmedfull study (doi)
"During this period, the average rate of CHD mortality according to the death certificates was higher for men in Lille (93/100,000 inh) and Strasbourg (84/100,000 inh) than in Toulouse (57/100,000 inh)." (abstract, results, passage verified)pubmed
"like the Sonnenburgs showed, you know, the husband and wife microbiology team at Stanford, they took volunteers and they gave them a great plant fiber, inulin, which is, you know, present in artichokes and asparagus and chicory family vegetables, Jerusalem artichokes, and they looked at inflammatory markers and they looked at gut microbiome diversity. And lo and behold, nothing changed... So then they repeated the experiment and they gave them fermented foods. In this case, it was mostly yogurts and kefir, kefirs. And lo and behold, the combination of the plant fiber plus the products of fermentation, which are postbiotics, then and only then they got improved gut microbiome diversity, and then and only then did their inflammatory markers go down." (said at 0:46:07)
The speaker accurately summarizes the core comparative findings of the 2021 Stanford study led by Justin and Erica Sonnenburg (PMID 34256014), but misdescribes the study's design and interventions. The randomized trial compared two parallel dietary arms in 36 healthy adults over 17 weeks: a high-fiber diet (averaging ~45 g/day from diverse whole plant foods, not isolated inulin supplementation) versus a high-fermented-food diet (including yogurt, kefir, fermented cottage cheese, kimchi, and kombucha). In the high-fiber arm, microbial diversity remained stable and inflammatory cytokine scores did not change overall. In contrast, the fermented-food diet steadily increased gut microbiota diversity and decreased 19 inflammatory markers. The trial was a parallel comparison of these two diets, rather than a sequential experiment testing isolated inulin followed by a combination of inulin and fermented foods.
"Using a 17-week randomized, prospective study (n = 18/arm) combined with -omics measurements of microbiome and host, including extensive immune profiling, we found diet-specific effects. The high-fiber diet increased microbiome-encoded glycan-degrading carbohydrate active enzymes (CAZymes) despite stable microbial community diversity. Although cytokine response score (primary outcome) was unchanged, three distinct immunological trajectories in high-fiber consumers corresponded to baseline microbiota diversity. Alternatively, the high-fermented-food diet steadily increased microbiota diversity and decreased inflammatory markers." (abstract, results, passage verified)pubmedfull study (doi)
"And polyphenols actually are really good at uncoupling mitochondria. And we could spend an hour talking about that, but let's just say they're mitochondrial protective agents." (said at 0:48:55)
Preclinical and biochemical literature demonstrates that various dietary polyphenols (such as quercetin, resveratrol, and chlorogenic acid) act as mitochondrial uncouplers by dissipating the mitochondrial membrane potential via protonophore mechanisms and by inducing uncoupling proteins (e.g., UCP1). These actions are frequently associated in mechanistic studies with reduced mitochondrial reactive oxygen species production and metabolic regulation.
"The results showed that constituents (chlorogenic acid, orientin, quercetin, hyperoside, and rutin) of L. cardiaca herb extract uncouple (by 20-90 %) mitochondrial oxidation from phosphorylation, partially inhibit (by ~ 40 %) the mitochondrial respiratory chain in cases of pyruvate and malate as well as succinate oxidation, and effectively attenuate the generation of free radicals in mitochondria." (abstract, results, passage verified)pubmedfull study (doi)
"The ability of polyphenols to dissipate the MMP (Δψ m ) by a protonophore mechanism has been known for more than 50 years. However, researchers focus primarily on the downstream molecular effects of Δψ m dissipation and mitochondrial uncoupling." (abstract, results, passage verified)pubmedfull study (doi)
"interestingly enough, uh we're fruit predators, uh and only fruit predators have color vision—um us and great apes and bees and uh so on, hummingbirds." (said at 0:51:20)
The claim that color vision exists exclusively in fruit-eating animals is contradicted by evolutionary biology and comparative visual physiology. Color vision is widespread across the animal kingdom across diverse trophic niches, including carnivores, insectivores, and aquatic predators. Ancestral vertebrates possessed multiple cone photoreceptor types enabling tetrachromatic or pentachromatic color vision, which is preserved in many modern fish, amphibians, reptiles, and birds. While the re-evolution of trichromatic color vision in catarrhine primates is hypothesized to have been influenced by foraging for ripe fruit and tender leaves, most non-frugivorous vertebrates and many non-frugivorous invertebrates (such as predatory mantis shrimp, jumping spiders, and nectar-feeding bees and hummingbirds) possess well-developed color vision.
"Detailed ultrastructural analysis reveals that all five receptor types in G. australis are cone-like, whereas N. forsteri possesses four cone types and a single type of rod. Each receptor type also contains a different visual pigment (opsin gene); that is, LWS, SWS1, SWS2, RhA and RhB in G. australis and LWS, SWS1, SWS2, Rh1 and Rh2 in N. forsteri, all of which are expressed within the retina and are sensitive to different parts of the electromagnetic spectrum, providing the potential for pentachromatic and tetrachromatic color vision, respectively." (abstract, results, passage verified)pubmedfull study (doi)
"We review studies concerning the circuit mechanisms mediating opponent interactions in a range of species, from tetrachromatic fish with diverse color opponent cell types to common dichromatic mammals where cone opponency is restricted to a subset of specialized circuits. Distinct among mammals, primates have reinvented trichromatic color vision using novel strategies to incorporate evolution of an additional photopigment gene into the foveal structure and circuitry that supports high-resolution vision." (abstract, results, passage verified)pubmedfull study (doi)
"And we uh we inherited the gene, the mutation that you well know about from great apes that got rid of uricase, and it allowed us like great apes to take fructose and store it as fat for the winter." (said at 0:52:55)
Evolutionary and metabolic literature establishes that hominoids (humans and great apes) share pseudogenizing mutations in the urate oxidase (uricase) gene that occurred in ancestral hominoids during the mid-Miocene (approximately 12–15 million years ago). Uricase degrades uric acid; its loss leads to higher circulating uric acid levels upon fructose ingestion, which acts as a metabolic amplifier to enhance lipogenesis and promote fat storage, thought to have provided a selective survival advantage during periods of seasonal cooling and fruit scarcity.
"Humans lack the ability to synthesize vitamin C due to a mutation in L-gulono-lactone oxidase that occurred during the late Eocene, and humans have higher serum uric acid levels due to a mutation in uricase that occurred in the mid Miocene. In this paper we review the hypothesis that these mutations have in common the induction of oxidative stress that may have had prosurvival effects to enhance the effects of fructose to increase fat stores." (abstract, results, passage verified)pubmed
"Twice in history, mutations occurred during periods of mass extinction that enhanced the activity of fructose to generate fat, with the first being a mutation in vitamin C metabolism during the Cretaceous-Paleogene extinction (65 million years ago) and the second being a mutation in uricase that occurred during the Middle Miocene disruption (12-14 million years ago)." (abstract, results, passage verified)pubmedfull study (doi)
"And we know for instance from Akkermansia studies looking at dead Akkermansia versus living Akkermansia that dead Akkermansia literally do contain messages that are useful." (said at 0:54:50)
Preclinical and human randomized controlled trials demonstrate that non-viable, pasteurized Akkermansia muciniphila retains and in some parameters enhances its metabolic efficacy compared to live bacteria. Researchers identified that specific heat-stable outer membrane proteins, such as Amuc_1100, interact directly with host cell receptors (such as Toll-like receptor 2) to signal and trigger metabolic benefits, including improved insulin sensitivity, reduced insulinemia, and enhanced gut barrier function.
"Unexpectedly, we discovered that pasteurization of A. muciniphila enhanced its capacity to reduce fat mass development, insulin resistance and dyslipidemia in mice. These improvements were notably associated with a modulation of the host urinary metabolomics profile and intestinal energy absorption. We demonstrated that Amuc_1100, a specific protein isolated from the outer membrane of A. muciniphila, interacts with Toll-like receptor 2, is stable at temperatures used for pasteurization, improves the gut barrier and partly recapitulates the beneficial effects of the bacterium." (abstract, results, passage verified)pubmedfull study (doi)
"In this single-center study, we demonstrated that daily oral supplementation of 10 10 A. muciniphila bacteria either live or pasteurized for three months was safe and well tolerated. Compared to placebo, pasteurized A. muciniphila improved insulin sensitivity (+28.62 ± 7.02%, P = 0.002), and reduced insulinemia (-34.08 ± 7.12%, P = 0.006) and plasma total cholesterol (-8.68 ± 2.38%, P = 0.02)." (abstract, results, passage verified)pubmedfull study (doi)
"Eli Lilly, believe it or not, started as a bacteriophage company before the times of antibiotics." (said at 0:59:06)
Eli Lilly and Company was not founded as a bacteriophage company. The company was founded in May 1876 by Colonel Eli Lilly to manufacture standardized pharmaceutical preparations and medications—decades before bacteriophages were even discovered by Frederick Twort (1915) and Félix d'Hérelle (1917). While Eli Lilly did manufacture and commercialize bacteriophage biological products (such as Colo-lysate and Staphylo-lysate) in the 1930s during the pre-antibiotic era before abandoning them when chemical antibiotics emerged, it did not start as a bacteriophage enterprise.
"Bacteriophage therapy was widely used around the world in the 1930s and 1940s, and it is still used in Eastern Europe and the former Soviet Union. However, phage therapy was all but abandoned in the West after antibiotics became widely available." (abstract, passage verified)openalexfull study (doi)
"I have a number of patients who have a lot of Akkermansia, but they don't produce doodly-squat worth of short-chain fatty acids even though that bug is in there." (said at 1:03:42)
The speaker's observation that high abundance of Akkermansia muciniphila does not necessarily correspond to high total short-chain fatty acid (SCFA) production is supported by microbiological and clinical metabolomic studies. While A. muciniphila ferments host mucin to produce acetate and propionate, overall colonic SCFA production—particularly butyrate—depends on fermentable dietary fiber intake and cross-feeding interactions with syntrophic butyrate-producing species (such as Faecalibacterium prausnitzii, Eubacterium hallii, and Anaerostipes caccae). In human cohort studies, individual taxon abundances, including A. muciniphila, do not consistently correlate with high fecal SCFA concentrations across diverse clinical phenotypes.
"Mucus degradation and fermentation by A. muciniphila are known to result in the liberation of oligosaccharides and subsequent production of acetate, which becomes directly available to microorganisms in the vicinity of the intestinal mucosa. Coculturing experiments of A muciniphila with non-mucus-degrading butyrate-producing bacteria Anaerostipes caccae , Eubacterium hallii , and Faecalibacterium prausnitzii resulted in syntrophic growth and production of butyrate." (abstract, results, passage verified)pubmedfull study (doi)
"Microbe-SCFA associations differed across groups and revealed key taxa including Dorea sp. CAG:317 and Bifidobacterium pseudocatenulatum in IBS-D and Akkermansia muciniphila and Prevotella copri in IBS-C that that could underlie subtype-specific microbially-mediated mechanisms... Several SCFA-producing species demonstrated inverse correlations with SCFA." (abstract, results, passage verified)pubmedfull study (doi)